Zevra Therapeutics (ZVRA) Gross Profit (2019 - 2026)
Zevra Therapeutics (ZVRA) posted Gross Profit of $36.01 million for Q3 2026, up 44.8% from $24.86 million a year earlier but down 5.7% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Gross Profit (2019 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Gross Profit at Zevra Therapeutics was $141.14 million, up 107.3% year-over-year; for FY2025, it was $90.02 million, up 455.8% from FY2024.
- Annual Gross Profit shows a four-year compound annual growth rate of 35.6% (FY2021 to FY2025).
- In prior years, Zevra Therapeutics' Gross Profit was $16.2 million in FY2024 (-36.0%), $25.29 million in FY2023 (+154.4%), $9.94 million in FY2022 (-62.6%) and $26.59 million in FY2021.
- Quarterly Gross Profit has run from a low of $876,000 in Q2 2024 to a high of $38.18 million in Q2 2026 over five years.
- On a year-over-year basis, Gross Profit has increased in each of the last four quarters, with growth averaging 165.2% over the last six quarters.
- The strongest year-over-year quarter for Gross Profit in the past five years was Q2 2023, with growth of 523.9%; the weakest was Q2 2024, with a decline of 88.8%.
- According to Business Quant data, Gross Profit for the three prior quarters was $38.18 million (Q2 2026), $34.32 million (Q1 2026) and $32.64 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 36.01 Mn |
| Jun 30, 2026 | 38.18 Mn |
| Mar 31, 2026 | 34.32 Mn |
| Dec 31, 2025 | 32.64 Mn |
| Sep 30, 2025 | 24.86 Mn |
| Jun 30, 2025 | 13.52 Mn |
| Mar 31, 2025 | 19.06 Mn |
| Dec 31, 2024 | 10.65 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 876,000.00 |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 11.69 Mn |
| Sep 30, 2023 | 2.75 Mn |
| Jun 30, 2023 | 7.79 Mn |
| Mar 31, 2023 | 3.05 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2022 | 2.73 Mn |
| Jun 30, 2022 | 1.25 Mn |
| Mar 31, 2022 | 3.96 Mn |
| Dec 31, 2021 | 2.52 Mn |
API Access
Zevra Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();